Laser nanobubbles induce immunogenic cell death in breast cancer
Source abstract
Abstract
Recent advances in immunotherapy have highlighted a need for therapeutics that initiate immunogenic cell death in tumors to stimulate the body's immune response to cancer. This study examines whether laser-generated bubbles surrounding nanoparticles ("nanobubbles") induce an immunogenic response for cancer treatment. A single nanosecond laser pulse at 1064 nm generates micron-sized bubbles surrounding gold nanorods in the cytoplasm of breast cancer cells. Cell death occurred in cells treated with nanorods and irradiated, but not in cells with irradiation treatment alone. Cells treated with nanorods and irradiation had increased damage-associated molecular patterns (DAMPs), including increased expression of chaperone proteins human high mobility group box 1 (HMGB1), adenosine triphosphate (ATP), and heat shock protein 70 (HSP70). This enhanced expression of DAMPs led to the activation of dendritic cells. Overall, this treatment approach is a rapid and highly specific method to eradicate tumor cells with simultaneous immunogenic cell death signaling, showing potential as a combination strategy for immunotherapy.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics · Laser-Ablation Synthesis of Nanoparticles
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering
The University of Texas at Austin
USA
Department of Electrical and Computer Engineering
Department of Chemistry and Biochemistry
Texas State University
Funding
Cancer Prevention and Research Institute of Texas · American Heart Association · U.S. Department of Defense · National Institutes of Health
References (55)
Show source-provided references
1. Maio · J. Clin. Oncol. · 2015 · 33 · 119110.1200/JCO.2014.56.6018 ↗
2. Hodi · N. Engl. J. Med. · 2010 · 363 · 71110.1056/NEJMoa1003466 ↗
3. Wei · Cancer Discovery · 2018 · 8 · 106910.1158/2159-8290.CD-18-0367 ↗
4. Nanda · J. Clin. Oncol. · 2016 · 34 · 246010.1200/JCO.2015.64.8931 ↗
5. Sharma · Science · 2015 · 348 · 5610.1126/science.aaa8172 ↗
6. Forde · N. Engl. J. Med. · 2018 · 378 · 197610.1056/NEJMoa1716078 ↗
7. Kepp · OncoImmunology · 2014 · 3 · e95569110.4161/21624011.2014.955691 ↗
8. Kroemer · Annu. Rev. Immunol. · 2013 · 31 · 5110.1146/annurev-immunol-032712-100008 ↗
9. Krysko · Nat. Rev. Cancer · 2012 · 12 · 86010.1038/nrc3380 ↗
10. Li · Chem. Sci. · 2020 · 11 · 742910.1039/D0SC00293C ↗
11. O'Neal · Cancer Lett. · 2004 · 209 · 17110.1016/j.canlet.2004.02.004 ↗
12. Hirsch · Proc. Natl. Acad. Sci. U. S. A. · 2003 · 100 · 1354910.1073/pnas.2232479100 ↗
13. Loo · Technol. Cancer Res. Treat. · 2004 · 3 · 3310.1177/153303460400300104 ↗
14. Li · ACS Appl. Bio Mater. · 2020 · 3 · 832110.1021/acsabm.0c01272 ↗
15. Toraya-Brown · Nanomedicine · 2014 · 10 · 127310.1016/j.nano.2014.01.011 ↗
16. Frey · Int. J. Hyperthermia · 2012 · 28 · 52810.3109/02656736.2012.677933 ↗
17. Skitzki · Curr. Opin. Invest. Drugs · 2009 · 10 · 550
18. Calderwood · Int. J. Hyperthermia · 2005 · 21 · 71310.1080/02656730500340794 ↗
19. Moy · Adv. Drug Delivery Rev. · 2017 · 114 · 17510.1016/j.addr.2017.06.008 ↗
20. Li · Chem. Commun. · 2020 · 56 · 138910.1039/C9CC08447A ↗
21. Bear · PLoS One · 2013 · 8 · e6907310.1371/journal.pone.0069073 ↗
22. Chen · Nat. Commun. · 2016 · 7 · 1319310.1038/ncomms13193 ↗
23. Ma · ACS Nano · 2019 · 13 · 1196710.1021/acsnano.9b06040 ↗
24. Huang · J. Biomed. Opt. · 2010 · 15 · 05800210.1117/1.3486538 ↗
25. Pitsillides · Biophys. J. · 2003 · 84 · 402310.1016/S0006-3495(03)75128-5 ↗
26. Boutopoulos · J. Biophotonics · 2016 · 9 · 2610.1002/jbio.201500135 ↗
27. Patino · Nanoscale · 2015 · 7 · 532810.1039/C5NR00114E ↗
28. Schnarr · Adv. Healthcare Mater. · 2013 · 2 · 97610.1002/adhm.201300003 ↗
29. Ratto · Adv. Funct. Mater. · 2016 · 26 · 717810.1002/adfm.201600836 ↗
30. Alkilany · Small · 2009 · 5 · 70110.1002/smll.200801546 ↗
31. Hauck · Small · 2008 · 4 · 15310.1002/smll.200700217 ↗
32. Qiu · Biomaterials · 2010 · 31 · 760610.1016/j.biomaterials.2010.06.051 ↗
33. H. T. M. Nguyen , N.Katta , J. A.Widman , L. J.Suggs , T. E.Milner and J. W.Tunnell , in Biophotonics Congress: Biomedical Optics 2020 (Translational, Microscopy, OCT, OTS, BRAIN) (2020), paper TTu1B.5 , Optical Society of America , 2020 , p. TTu1B.5
34. Siems · New J. Phys. · 2011 · 13 · 04301810.1088/1367-2630/13/4/043018 ↗
35. Lukianova-Hleb · ACS Nano · 2010 · 4 · 210910.1021/nn1000222 ↗
36. Kitz · Biomed. Opt. Express · 2011 · 2 · 29110.1364/BOE.2.000291 ↗
37. Epstein · J. Chem. Phys. · 1950 · 18 · 150510.1063/1.1747520 ↗
38. Ljunggren · Colloids Surf., A · 1997 · 129–130 · 15110.1016/S0927-7757(97)00033-2 ↗
39. Zhang · Sci. China, Ser. G: Phys., Mech. Astron. · 2008 · 51 · 21910.1007/s11433-008-0026-5 ↗
40. Parmarand · ChemXpress · 2016 · 9 · 046
41. Boulais · Nano Lett. · 2012 · 12 · 476310.1021/nl302200w ↗
42. Dutta · J. Theor. Biol. · 1995 · 176 · 43310.1006/jtbi.1995.0211 ↗
43. Richardson · Proc. Natl. Acad. Sci. U. S. A. · 2020 · 117 · 1006710.1073/pnas.1916641117 ↗
44. Philipp · J. Fluid Mech. · 1998 · 361 · 7510.1017/S0022112098008738 ↗
45. Brujan · Phys. Fluids · 2001 · 14 · 8510.1063/1.1421102 ↗
46. Bezu · Front. Immunol. · 2015 · 6 · 187
47. Lutz · J. Immunol. Methods · 1999 · 223 · 7710.1016/S0022-1759(98)00204-X ↗
48. Helft · Immunity · 2015 · 42 · 119710.1016/j.immuni.2015.05.018 ↗
49. Lutz · Immunobiology · 2004 · 209 · 7910.1016/j.imbio.2004.03.001 ↗
50. Villadangos · Immunol. Rev. · 2005 · 207 · 19110.1111/j.0105-2896.2005.00317.x ↗
51. Sapoznikov · Nat. Immunol. · 2008 · 9 · 38810.1038/ni1571 ↗
52. Pattani · J. Nanopart. Res. · 2015 · 17 · 2010.1007/s11051-014-2822-3 ↗
53. Park · Opt. Express · 2008 · 16 · 159010.1364/OE.16.001590 ↗
54. Lapotko · Lasers Surg. Med. · 2006 · 38 · 63110.1002/lsm.20359 ↗
55. Peeters · Biomed. Opt. Express · 2012 · 3 · 43510.1364/BOE.3.000435 ↗